Rio Conference Opens as HIV Funding Cuts Reshape the Epidemic

Delegates arriving at the 26th International AIDS Conference in Rio de Janeiro on Monday carried an awkward pairing into the hall. The science of HIV prevention has seldom looked stronger. The financing that moves it from trial sites to clinics has seldom looked weaker.

UNAIDS chose the opening day of the meeting, which runs to 31 July under the theme "Rethink. Rebuild. Rise.", to publish a report titled United to End AIDS. The agency had flagged the launch in a media advisory on 21 July, promising a full accounting of the disruption absorbed during 2025 and of the countries where new infections are climbing again. The venue was chosen with care. Rio is the first global gathering of the HIV field since governments signed off on new targets at a United Nations high-level meeting in June, and the first at which the consequences of the past eighteen months can be measured rather than forecast.

Damage logged in a single year

The scale of the retrenchment is no longer contested. Global development assistance fell by 23 per cent in 2025, the steepest one-year decline on record, according to UNAIDS figures published in June and summarised by UN News. HIV programmes took a disproportionate share of that contraction. Testing in high-burden settings fell by 22 per cent between 2024 and 2025. Spending on condoms was reduced by more than 90 per cent in some national programmes, a cut deep enough to remove a commodity that has anchored prevention budgets for three decades.

The agency itself was not insulated. Executive Director Winnie Byanyima has said UNAIDS lost roughly a quarter of its own budget over the same period. UN News quoted her describing the episode as "the most serious disruption in the HIV response" since the world first mobilised against the disease. Her framing has been consistent since the spring: the technical questions are largely settled, and what remains is a question of political willingness to pay.

Independent tallies point the same way. A survey by amfAR of 166 organisations working across 46 countries, reported by Al Jazeera on 21 July, found that more than 1,700 clinics had closed and over 16,000 staff had lost their jobs after awards were delayed or cancelled. Roughly 77,000 fewer children received treatment supported by the United States President's Emergency Plan for AIDS Relief during 2025, a decline of about 14 per cent. Three quarters of the organisations surveyed stopped serving populations at highest risk. An amfAR policy associate, Elise Lankiewicz, told the outlet the disruption was "incredibly widespread".

The Washington Blade, citing the International AIDS Society, reported that 1,010 public health facilities, 325 access points and 126 drop-in centres have shut as a consequence of United States funding decisions, with 52 per cent of implementing partners seeing awards terminated and 77 per cent forced to restrict operations. The United States Agency for International Development closed on 1 July 2025, removing the administrative machinery through which much of that money once flowed.

Progress no longer moves in one direction

For most of the past fifteen years the epidemiological picture was uniform in shape if not in pace. That uniformity has broken. Between 2010 and 2025, new infections fell by 30 per cent in the Caribbean and by 13 per cent across western and central Europe and North America. Over the same window they rose by 15 per cent in eastern Europe and central Asia, by 13 per cent in Latin America and by 77 per cent in the Middle East and North Africa, according to the data underpinning the UNAIDS report.

The aggregate numbers still flatter the response. UNAIDS counted 1.2 million new infections and 570,000 AIDS-related deaths in 2025, the lowest totals in three decades, with deaths down 56 per cent and infections down 43 per cent since 2010. Yet close to nine million people living with HIV remain untreated, and the 2030 targets adopted in June, including 40 million people on antiretroviral therapy, assume a rate of progress that the current funding base does not support.

UNAIDS has modelled the alternative. If the reductions become permanent, the agency projects 6.6 million additional infections and 4.2 million additional AIDS-related deaths by 2029. Those figures are not a forecast of what will happen so much as a price tag attached to inaction, and they have become the central number in the advocacy arithmetic on display in Rio.

Prevention absorbs the first shock

Prevention has taken the sharpest hit, which is characteristic of how health budgets contract. Treatment carries an immediate political cost when it stops. Prevention fails quietly, and its failures surface years later. Prevention accounts for about 11 per cent of total HIV spending, and initiations of pre-exposure prophylaxis fell by 38 per cent across 62 countries between 2024 and 2025.

Community organisations, which deliver most services to marginalised groups, have contracted further still. A review of 79 organisations across 47 countries cited by UN News found support services for people living with HIV down by half, services for sex workers down 82 per cent and services for men who have sex with men down 85 per cent. These are the delivery channels through which any new prevention technology must eventually pass, and their erosion is the reason HIV funding cuts translate into lost coverage faster than headline budget lines suggest.

Financing shifts from donors to finance ministries

The strategic response taking shape in Rio has less to do with restoring old donor flows than with rebuilding the financing structure beneath them. UNAIDS has set out three priorities for the conference: implementing the targets in the Global AIDS Strategy for 2026 to 2031, protecting prevention and community services for key populations, and securing sustainable financing from a mix of international and domestic sources.

That last item is the hardest. Domestic resource mobilisation in the countries carrying the heaviest burden competes with debt service, energy subsidies and the recurrent costs of primary care. Byanyima has argued that African governments should reconsider how health is financed rather than wait for donors to return, a position she repeated in remarks reported by Africanews in July. The counterargument, familiar from a decade of global health financing debates, is that fiscal space cannot be created by exhortation.

Between the podium and the clinic

The conference is also a showcase for prevention tools that did not exist a decade ago, including twice-yearly injectable pre-exposure prophylaxis. Beatriz Grinsztejn, president of the International AIDS Society, has framed the tension precisely, noting that scientific advances "cannot save lives if they never reach the people who need them", in comments reported by the Washington Blade.

That is the analytical core of the week. The HIV field has spent twenty years building the case that treatment and prevention at scale are among the most cost-effective interventions in global health, a case reinforced by the more than 26 million lives the International AIDS Society attributes to PEPFAR since 2003. The case did not lose an argument in 2025. It lost a budget line. Rio will test whether the distinction still matters to the governments writing the cheques, and whether the epidemiological cost of the current HIV funding cuts is treated as a reason to reverse them or as an accepted condition of a smaller aid architecture.